Table 5.

Comparison of the relationship between metastasis status and TNFRSF11A single nucleotide polymorphisms in the patient groups.

SNPs	Alleles	Patients With BRCA1 or BRCA2 Mutations			Patients Without BRCA1 or BRCA2 Mutations
		Negative Metastasis n (%)	Positive Metastasis n (%)	p Value	Negative Metastasis n (%)	Positive Metastasis n (%)	p Value
rs4941129	TT	3 (50.0)	4 (36.4)		6 (54.5)	8 (47.1)	0.696
	CT	2 (33.3)	7 (63.6)	0.156	5 (45.5)	8 (47.1)
	CC	1 (16.7)	0 (0.0)		0 (0.0)	1 (5.9)
rs884205	CC	3 (50.0)	8 (72.7)		4 (36.4)	11 (64.7)	0.338
	AC	3 (50.0)	2 (18.2)	0.598	6 (54.5)	5 (29.4)
	AA	0 (0.0)	1 (9.1)		1 (9.1)	1 (5.9)
rs17069904	GG	4 (66.7)	9 (81.8)		9 (81.8)	14 (82.4)	0.971
	AG	2 (33.3)	1 (9.1)	0.588	2 (18.2)	3 (17.6)
	AA	0 (0.0)	1 (9.1)		0 (0.0)	0 (0.0)
rs34739845	AA	5 (83.3)	9 (81.8)		7 (63.6)	15 (88.2)	0.228
	AG	1 (16.7)	2 (18.2)	0.724	3 (27.3)	2 (11.8)
	GG	0 (0.0)	0 (0.0)		1 (9.1)	0 (0.0)
rs9646629	GG	2 (33.3)	6 (54.5)		1 (9.1)	7 (41.2)	0.161
	CG	4 (66.7)	3 (27.3)	0.550	7 (63.6)	8 (47.1)
	CC	0 (0.0)	2 (18.2)		3 (27.3)	2 (11.8)
rs4485469	AA	4 (66.7)	6 (54.5)		0 (0.0)	4 (23.5)	0.138
	AG	1 (16.7)	3 (27.3)	0.158	8 (72.7)	7 (41.2)
	GG	1 (16.7)	2 (18.2)		3 (27.3)	6 (35.3)

SNPs: single nucleotide polymorphisms.